Financial Snapshot For September 2004
In need of a boost.
Archive for October, 2004
109898799986889078
October 28, 2004Biotech: The “safe” drug bet?
“Defensive pharma stocks have struggled while biotechs have flourished. Can this continue?”
109874119453756407
October 25, 2004Biotech execs have a sense of humor about elusive profits
When Ernst & Young’s annual report on the biotechnology industry last year predicted that as a whole, the industry would turn profitable for the first time in 2008, some long-term industry veterans gave a knowing heard-that-one-before chuckle.
109856128463932864
October 23, 2004Is That a Pilot in Your Pocket?
“Somewhere in Florida, 25,000 disembodied rat neurons are thinking about flying an F-22. “
109822895645610513
October 19, 2004Foresight or folly? Generics firms’ foray into NCEs
A number of generics firms have, over the last few years, veered off the path and started to develop innovative drugs in their own right. In a time when generics firms are showing the greatest growth in the pharmaceutical sector, what has driven them to venture into new territory?
109814479590607417
October 18, 2004How many trillions for a drug miracle?
“Here’s a quick thought experiment about the current system for developing and paying for miracle drugs: Would it be worth almost any price to develop a drug with a better than 50-50 probability of conquering many of the world’s most deadly diseases? “
109787075409196548
October 15, 2004State biotech sector no miracle drug for creation of jobs
“Ruth Scott’s job is to be the No. 1 cheerleader for biotechnology in Washington state. But when politicians talk up the industry as a silver bullet for job growth, she cringes.”
109776742184150347
October 14, 2004Merck: Successor pill safer than Vioxx
Merck & Co., the US drug maker that recalled its Vioxx painkiller because of a link to heart disease, said short-term studies show the company’s planned successor pill, Arcoxia, is safer.
109770828380000708
October 13, 2004Big pharma’s pain could be biotech’s gain
“Current problems besetting ‘big pharma’ could have a silver lining for the smaller biotechnology sector, some investors believe.”
109761495639718717
October 12, 2004Few Americans Buy Meds Online
“Few American adults have bought prescription drugs through the internet, despite rising drug costs and increased pressure to import cheaper drugs from abroad, according to a new study released Sunday. “
